CN103127485A - Medicine for treating tumors - Google Patents
Medicine for treating tumors Download PDFInfo
- Publication number
- CN103127485A CN103127485A CN2013100723612A CN201310072361A CN103127485A CN 103127485 A CN103127485 A CN 103127485A CN 2013100723612 A CN2013100723612 A CN 2013100723612A CN 201310072361 A CN201310072361 A CN 201310072361A CN 103127485 A CN103127485 A CN 103127485A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- radix
- rhizoma
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating tumors. The medicine is prepared from the following Chinese herbal raw materials in parts by weight: 20-30 parts of hedyotis diffusa, 10-15 parts of barbed skullcap herb, 8-10 parts of wild chrysanthemum flower, 8-10 parts of air potato, 10-12 parts of selfheal, 8-12 parts of white mulberry root-bark, 6-10 parts of fructus forsythiae, 10-15 parts of common peony root, 10-15 parts of Chinese angelica, 8-10 parts of lucid ganoderma, 6-8 parts of kudzu wine root, 10-15 parts of tuckahoe, 10-15 parts of radix bupleuri, 3-5 parts of rhizoma cyperi, 2-3 parts of ginger and 2-3 parts of garlic. All the Chinese herbal raw materials are synergistically used for playing the effects of clearing away heat and toxic materials, swelling subsidence, removing stasis, tonifying qi and nourishing blood through dialectic compatibility; and the medicine disclosed by the invention can be used for activating non-viable non-apoptotic cells, inhibiting tumor cell growth and enhancing the immunity. Clinical tests prove that the medicine has a remarkable curative effect on tumor patients.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of tumor.
Background technology
Tumor (Tumor) be body under various carcinogenic factor effects, some cells of local organization lose the normal regulation to its growth on gene level, cause its clonal abnormality hypertrophy and the abnormality that forms.In prior art, the method for the treatment of tumor mainly adopts chemotherapy and radiation, although these two kinds of Therapeutic Method have certain curative effect, but can bring misery to patient during treating, so the patient has the feared state of mind for these two kinds of Therapeutic Method, is unfavorable for the treatment of disease.At present, the domestic Chinese medicine that many treatment tumors are also arranged, but therapeutic effect is not very desirable.
Summary of the invention
Based on above-mentioned technical problem, the invention provides a kind of medicine for the treatment of tumor.
Its technical solution is:
A kind of medicine for the treatment of tumor, it is that raw material of Chinese medicine by following weight portion proportioning is made: Herba Hedyotidis Diffusae 20-30 part, Herba Scutellariae Barbatae 10-15 part, Flos Chrysanthemi Indici 8-10 part, Rhizoma Dioscoreae Bulbiferae 8-10 part, Spica Prunellae 10-12 part, Cortex Mori 8-12 part, Fructus Forsythiae 6-10 part, Radix Paeoniae Rubra 10-15 part, Radix Angelicae Sinensis 10-15 part, Ganoderma 8-10 part, Radix Puerariae 6-8 part, Poria 10-15 part, Radix Bupleuri 10-15 part, Rhizoma Cyperi 3-5 part, Rhizoma Zingiberis Recens 2-3 part, Bulbus Allii 2-3 part.
Preferably, the weight portion proportioning of each raw material of Chinese medicine is: 25 parts of Herba Hedyotidis Diffusaes, 12 parts of Herba Scutellariae Barbataes, 10 parts of Flos Chrysanthemi Indicis, 10 parts of Rhizoma Dioscoreae Bulbiferaes, 12 parts of Spica Prunellaes, 10 parts of Cortex Mori, 8 parts of Fructus Forsythiaes, 12 parts of Radix Paeoniae Rubra, 12 parts of Radix Angelicae Sinensis, 8 parts of Ganodermas, 8 parts of Radix Puerariaes, 12 parts, Poria, 12 parts of Radix Bupleuri, 4 parts of Rhizoma Cyperis, 3 parts, Rhizoma Zingiberis Recens, 2 parts, Bulbus Allii.
Pharmacology of the present invention and beneficial effect are as follows:
tumor is early on the books in China's successive dynasties traditional Chinese medical science treatise, its appellation has indurated subcutaneous mass, malignant boil, tumor, rock, cancer etc., the traditional Chinese medical science thinks that the pathogeny of cancer is that the internal and external reasons that caused a disease accompanies each other and forms, the exopathogenic factor six climate exopathogens are not just, the endogenous cause of ill seven emotions are extreme, or diet impairment caused by overstrain, the factors combineds effect such as body constitution interior-deficiency cause the body yin and yang imbalance, function is impaired, positive QI-insufficiency, the meridians circulation is not smooth, QI-blood circulation is not normal, just not anti-heresy, heresy is taken advantage of void and is entered and local stagnation of QI-blood occurs, expectorant is solidifying wet poly-, pyretic toxicity pents up, zang-fu disharmony, interweave mutually, with the passing of time become disease, and then produce weakened body resistance mistake therefore, give birth in the cancer poison.
Selected each raw material of Chinese medicine of the present invention, Herba Hedyotidis Diffusae, Herba Scutellariae Barbatae, Flos Chrysanthemi Indici, Rhizoma Dioscoreae Bulbiferae, Spica Prunellae, Cortex Mori and Fructus Forsythiae have heat-clearing and toxic substances removing, the effect of dispersing swelling and dissipating binds; The effect that Radix Paeoniae Rubra and Radix Angelicae Sinensis have clots absorbing, subside a swelling, enrich blood, invigorate blood circulation; The effect that Radix Bupleuri, Rhizoma Cyperi have dispersing the stagnated live-QI to relieve the stagnation of QI, regulate the flow of vital energy; Poria, Ganoderma, Radix Puerariae, Rhizoma Zingiberis Recens and Bulbus Allii all have the effect of inhibition tumor cell growth.Above all medicines share, and play altogether the merit of heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, benefiting QI and nourishing blood, can activate non-viable non-apoptotic cell on the one hand, but inhibition tumor cell growth on the other hand, enhancing immunity.Evident in efficacy to tumor patient through clinical trial proof medicine of the present invention.
The specific embodiment
Take raw material of Chinese medicine by following proportioning:
Herba Hedyotidis Diffusae 25g, Herba Scutellariae Barbatae 12g, Flos Chrysanthemi Indici 10g, Rhizoma Dioscoreae Bulbiferae 10g, Spica Prunellae 12g, Cortex Mori 10g, Fructus Forsythiae 8g, Radix Paeoniae Rubra 12g, Radix Angelicae Sinensis 12g, Ganoderma 8g, Radix Puerariae 8g, Poria 12g, Radix Bupleuri 12g, Rhizoma Cyperi 4g, Rhizoma Zingiberis Recens 3g, Bulbus Allii 2g.
Preparation method is as follows:
Herba Hedyotidis Diffusae, Herba Scutellariae Barbatae, Flos Chrysanthemi Indici, Rhizoma Dioscoreae Bulbiferae, Spica Prunellae, Cortex Mori and Fructus Forsythiae after first taking is placed in the lump 300g water and soaked one hour, then decocts one hour, filters to get filtrate one and medicinal residues, the another device storage of filtrate one.Medicinal residues are added in 200g water decocted one hour again, filter to get filtrate two, filtrate one and filtrate two are merged, in temperature be under the condition of 80 ° of C concentrating under reduced pressure to become proportion be 1.2 thick paste.Remaining 9 flavor Chinese medicine powders are broken into 120 order fine powders, mixing, then add above-mentioned thick paste and with the thick paste mixing, then dry, pulverize and make the ball shape and namely get medicine of the present invention.
Clinical data
1. physical data
Random tumor patient 300 examples of selecting, male 250 examples wherein, female's 50 examples, 210 people in age 50-65 year, 80 people in 40-50 year, 10 people below 40 years old.
2. efficacy assessment standard
Recovery from illness: tumor disappears, and lesions position pain is eliminated, and has no lump when chemical examination or perspective, and livelihood restoration is normal.
Produce effects: the tumor atrophy, diminish, cancerous cell has no transfer, and pain obviously alleviates, but cancerous cell also disappears fully.
Effectively: tumor has no expansion, and cancerous cell has no transfer, and pain alleviates to some extent, but lump has no obviously and reduces.
Invalid: the tumor symptom loses and alleviates, and pain is still serious.
3. usage and dosage
Oral pill of the present invention, one time 4 (0.25g/ grain), 3 times on the one, 30 days is 1 course for the treatment of.
4. therapeutic effect
Take continuously 5 courses for the treatment of of pill of the present invention, wherein cure 162 examples, produce effects 78 examples, effective 52 examples, invalid 8 examples, total effective rate 97.33%.
5. model case
Zhang, the man, 64 years old, Qingdao of Shandong province people suffered from esophageal carcinoma, takes pill of the present invention, and rehabilitation after 5 months is followed up a case by regular visits to after half a year and is had no recurrence.
Lee, the female, 60 years old, Qingdao of Shandong province people suffered from tumor of bladder, takes pill of the present invention, and rehabilitation after 4 months is followed up a case by regular visits to after half a year and is had no recurrence.
Week certain, the man, 56 years old, people from Jinan City, Shandong Province suffered from bone tumor, takes pill of the present invention, rehabilitation after 3 months is followed up a case by regular visits to after 1 year and is had no recurrence.
Money, the man, 40 years old, people from Jinan City, Shandong Province suffered from pulmonary carcinoma, takes pill of the present invention, and rehabilitation after 5 months is followed up a case by regular visits to after 1 year and is had no recurrence.
Zheng, female, 53 years old, people from Weifang City, Shandong Province, carried out mammary cancer radical operation operation before 6 years, in August, 2012 check is found to transfer on lumbar vertebra bone, because health can not chemotherapy and operation, the same year, JIUYUE was taken pill of the present invention, and after 3 months, the check indices has all reached normally, foci disappearance.
Wu, the man, 75 years old, people from Weifang City, Shandong Province suffered from colon cancer, weak, have a sleepless night, eat liquid food, pain, take pill of the present invention, sleep was normal afterwards in 3 days, pain relief, can eat of dried food, after 2 courses for the treatment of, atrophy appears in tumor, continues to take 3 courses for the treatment of, and it is normal that indices all recovers.
Claims (2)
1. medicine for the treatment of tumor is characterized in that it is that raw material of Chinese medicine by following weight portion proportioning is made: Herba Hedyotidis Diffusae 20-30 part, Herba Scutellariae Barbatae 10-15 part, Flos Chrysanthemi Indici 8-10 part, Rhizoma Dioscoreae Bulbiferae 8-10 part, Spica Prunellae 10-12 part, Cortex Mori 8-12 part, Fructus Forsythiae 6-10 part, Radix Paeoniae Rubra 10-15 part, Radix Angelicae Sinensis 10-15 part, Ganoderma 8-10 part, Radix Puerariae 6-8 part, Poria 10-15 part, Radix Bupleuri 10-15 part, Rhizoma Cyperi 3-5 part, Rhizoma Zingiberis Recens 2-3 part, Bulbus Allii 2-3 part.
2. a kind of medicine for the treatment of tumor according to claim 1, is characterized in that the weight portion proportioning of each raw material of Chinese medicine is: 25 parts of Herba Hedyotidis Diffusaes, 12 parts of Herba Scutellariae Barbataes, 10 parts of Flos Chrysanthemi Indicis, 10 parts of Rhizoma Dioscoreae Bulbiferaes, 12 parts of Spica Prunellaes, 10 parts of Cortex Mori, 8 parts of Fructus Forsythiaes, 12 parts of Radix Paeoniae Rubra, 12 parts of Radix Angelicae Sinensis, 8 parts of Ganodermas, 8 parts of Radix Puerariaes, 12 parts, Poria, 12 parts of Radix Bupleuri, 4 parts of Rhizoma Cyperis, 3 parts, Rhizoma Zingiberis Recens, 2 parts, Bulbus Allii.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013100723612A CN103127485A (en) | 2013-03-07 | 2013-03-07 | Medicine for treating tumors |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013100723612A CN103127485A (en) | 2013-03-07 | 2013-03-07 | Medicine for treating tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103127485A true CN103127485A (en) | 2013-06-05 |
Family
ID=48488354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013100723612A Pending CN103127485A (en) | 2013-03-07 | 2013-03-07 | Medicine for treating tumors |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103127485A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103908495A (en) * | 2014-04-12 | 2014-07-09 | 陈欣 | Traditional Chinese medicine composition for improving postoperative immunity of cancer patient and preparation method of traditional Chinese medicine composition |
| CN104189804A (en) * | 2014-08-11 | 2014-12-10 | 孔令刚 | Traditional Chinese medicine composition for removing toxicity and resisting cancer |
| CN104208349A (en) * | 2014-08-21 | 2014-12-17 | 任有德 | Traditional Chinese medicine composition for treating cancers and preparation method thereof |
| CN111248384A (en) * | 2020-03-27 | 2020-06-09 | 陕西巨子生物技术有限公司 | Composite probiotic enzyme beverage and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101664536A (en) * | 2009-10-15 | 2010-03-10 | 赵金忠 | Traditional Chinese medicine composition for resisting tumors |
| CN101757562A (en) * | 2009-11-05 | 2010-06-30 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composition for treating mid-term malignant liver tumor symptoms and preparation method thereof |
| CN101797366A (en) * | 2010-04-21 | 2010-08-11 | 孙明海 | Drug composition for treating tumor |
| CN102488868A (en) * | 2011-12-26 | 2012-06-13 | 朱国付 | Tumor-treating pills |
| CN102641477A (en) * | 2012-05-14 | 2012-08-22 | 许俊斋 | Medicament for treating pancreatic cancer |
-
2013
- 2013-03-07 CN CN2013100723612A patent/CN103127485A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101664536A (en) * | 2009-10-15 | 2010-03-10 | 赵金忠 | Traditional Chinese medicine composition for resisting tumors |
| CN101757562A (en) * | 2009-11-05 | 2010-06-30 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composition for treating mid-term malignant liver tumor symptoms and preparation method thereof |
| CN101797366A (en) * | 2010-04-21 | 2010-08-11 | 孙明海 | Drug composition for treating tumor |
| CN102488868A (en) * | 2011-12-26 | 2012-06-13 | 朱国付 | Tumor-treating pills |
| CN102641477A (en) * | 2012-05-14 | 2012-08-22 | 许俊斋 | Medicament for treating pancreatic cancer |
Non-Patent Citations (2)
| Title |
|---|
| 吴志平等: "中药桑白皮化学成分及药理活性研究进展", 《中国野生植物资源》, no. 05, 25 October 2004 (2004-10-25) * |
| 林厚文等: "黄药子的研究进展", 《中草药》, no. 02, 25 February 2002 (2002-02-25) * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103908495A (en) * | 2014-04-12 | 2014-07-09 | 陈欣 | Traditional Chinese medicine composition for improving postoperative immunity of cancer patient and preparation method of traditional Chinese medicine composition |
| CN104189804A (en) * | 2014-08-11 | 2014-12-10 | 孔令刚 | Traditional Chinese medicine composition for removing toxicity and resisting cancer |
| CN104208349A (en) * | 2014-08-21 | 2014-12-17 | 任有德 | Traditional Chinese medicine composition for treating cancers and preparation method thereof |
| CN104208349B (en) * | 2014-08-21 | 2017-09-01 | 任有德 | A kind of Chinese medicine composition for the treatment of cancer and preparation method thereof |
| CN111248384A (en) * | 2020-03-27 | 2020-06-09 | 陕西巨子生物技术有限公司 | Composite probiotic enzyme beverage and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103784802B (en) | A kind of Chinese medicine composition for the treatment of diabetes | |
| CN102772778B (en) | Traditional Chinese medicine composition for treating summer heat-dampness | |
| CN101947304A (en) | Traditional Chinese medicinal composition for treating cold gastroenteropathy | |
| CN102688420A (en) | Traditional Chinese medicine decoction for treating psoriasis | |
| CN103721185B (en) | A kind of Chinese medicine for the treatment of sinking of QI due to deficiency of the spleen pattern of syndrome gastroptosis disease | |
| CN103127485A (en) | Medicine for treating tumors | |
| CN102600426B (en) | Chinese medicinal preparation for promoting blood circulation to remove blood stasis and preparation method thereof | |
| CN103316317A (en) | Traditional Chinese medicine composition for treating superficial gastritis | |
| CN102698210A (en) | Traditional Chinese medicine capable of invigorating spleen and supplementing qi and treating gastroptosis | |
| CN102861296B (en) | Pill inducing diuresis and reducing edema for treating gonarthromeningitis | |
| CN102526670A (en) | Traditional Chinese medicinal composition for treating cholecystitis and preparation method thereof | |
| CN102600414B (en) | Chinese medicinal composition for treating cervical spondylosis | |
| CN105521332A (en) | Traditional Chinese medicinal composition for treating anal fissure, and preparation method and application thereof | |
| CN104689252A (en) | Traditional Chinese preparation for treating Wegener granulomatosis and preparation method thereof | |
| CN100534468C (en) | Orally-administered traditional Chinese medicine for treating irritable bowel syndrome | |
| CN104306847A (en) | Six-ingredient qi-tonifying capsule and preparation process thereof | |
| CN104162127A (en) | Traditional Chinese medicinal preparation for curing heart failure | |
| CN103656199B (en) | A kind of Chinese medicine for the treatment of deficiency of kidney yin syndrome cough | |
| CN103100026B (en) | Traditional Chinese medicine composition for treating postoperative dyspepsia and sour regurgitation caused by gastrectomy and preparation method thereof | |
| CN102406913A (en) | Chinese medicinal composition for treating melancholia | |
| CN104958736A (en) | Application of Chinese medicinal preparation in preparation of medicament for treating acute gastroenteritis | |
| CN105999196A (en) | Traditional Chinese medicinal preparation for treating acute peritonitis and preparation method | |
| CN104857491A (en) | Traditional Chinese medicine for treating acute icteric hepatitis | |
| CN103977213A (en) | Health care medicine for treating spleen and stomach deficiency-cold type chronic gastritis | |
| CN104906497A (en) | Traditional Chinese medicine preparation for treating eosinophilic fasciitis and preparation method of traditional Chinese medicine preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130605 |